SCHEMBL21881749

SCHEMBL21881749

c1ccc(-c2ncnc(-c3cccc(C4(c5ccccc5)c5ccccc5-c5ccccc54)c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
MAPT P10636 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 2/20 0.42
OPRK1 P41145 1/20 0.42
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
PDGFRB P09619 2/20 0.33
CSF1R P07333 1/20 0.33
GSK3A P49840 1/20 0.33
CDK9 P50750 1/20 0.33
CDK5 Q00535 1/20 0.33
ACVR1 Q04771 1/20 0.33
CDK5R1 Q15078 1/20 0.33
TAOK1 Q7L7X3 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
BACE1 P56817 2/20 0.33
KCNH2 Q12809 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166316 0.99 KMT2A (0.40) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL12166311 0.96 SMN1; SMN2 (0.38) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL21881787 0.92 MEN1 (0.40) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL22473031 0.91 MEN1 (0.47) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL19293872 0.91 MEN1 (0.47) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL30865507 0.91 PDK2 (0.36) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL12166448 0.91 KCNQ2 (0.33) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL12166302 0.90 MEN1 (0.38) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL12166317 0.90 MEN1 (0.44) KMT2AMEN1MAPTSMN1; SMN2KDM4E
SCHEMBL23351452 0.88 MEN1 (0.45) KMT2AMEN1MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
WO-2023134228-A1 NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2023-07-20 WO disclosed
US-20200161559-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer NOVALED GMBH (DE) 2020-05-21 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 KMT2A 3297/4885MEN1 762/4885MAPT 4555/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 KMT2A 3297/4885MEN1 762/4885MAPT 4555/4885
US-20200161559-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer C1S, YAP1, ESR1 KMT2A 2561/4885MEN1 715/4885MAPT 4392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.